FDA Fines 20 Retailers for Illegal Sale of ELFBAR E-cigarettes

Elfbar by 2FIRSTS
Feb.27.2024
FDA Fines 20 Retailers for Illegal Sale of ELFBAR E-cigarettes
FDA files civil penalties against 20 retailers for unauthorized ELFBAR e-cigarette sales, seeking up to $20,678 in fines per violation.

The U.S. Food and Drug Administration (FDA) announced on February 26 that it has filed civil monetary penalty complaints (CMPs) against 20 retail entities for selling unauthorized ELFBAR e-cigarette products. The FDA had previously issued warning letters to each retailer regarding their sale of unauthorized e-cigarette products. However, subsequent inspections found that these retailers failed to correct their violations, and the agency is now seeking the maximum penalty amount of $20,678 for each retailer for each individual violation.

 

Including the complaints announced today, the FDA has filed CMP complaints against over 100 retailers, accusing them of illegally selling ELFBA re-cigarette products. Data shows that these products are appealing to teenagers. According to the 2023 National Youth Tobacco Survey, ELFBA is the most commonly used brand among adolescent e-cigarette users in the United States; over half of middle and high school students who reported using e-cigarettes in the past 30 days stated that they used ELFBAR products during that period.

 

Dr. Brian King, Director of the FDA's Center for Tobacco Products, stated, "These retailers have failed to address the violations regarding the sale of unauthorized e-cigarette products as previously warned by the FDA. Their continued illegal actions are unacceptable, and as today's actions demonstrate, we are committed to holding them accountable."

 

Currently, $20,678 is the maximum civil penalty amount that the FDA can seek from individual retailers for a single violation, consistent with similar CMPs filed in September, November, and December 2023 for retailers selling unauthorized ELFBAR products. Retailers may choose to pay the fine, enter into a settlement agreement based on mitigating factors, request an extension for a response, or submit a response and request a hearing. Retailers who fail to take action within 30 days of receiving a complaint are at risk of default judgment for the full penalty amount.

 

Ele Ibarra-Pratt, acting director of the Enforcement and Compliance Office at the FDA Center for Tobacco Products, stated, "We closely monitor the entire supply chain, including retailers, to ensure compliance with the law. This includes tracking inspections and monitoring of retailers who have received warning letters, and taking enforcement actions as necessary, including filing civil monetary penalty complaints and seeking seizure and injunction."

 

The CMP action is the latest initiative by the FDA to continuously crack down on unauthorized e-cigarette products throughout the supply chain, especially those popular among teenagers. As of February 15th, the FDA has issued warning letters to over 440 retailers, including brick-and-mortar stores and online retailers, and has filed 100 CMP lawsuits accusing them of selling unauthorized tobacco products.

 

In addition to actions against retailers, the FDA has issued over 660 warning letters to manufacturers, importers, and distributors, accusing them of illegally selling and/or distributing unauthorized new tobacco products, including e-cigarettes. The agency has also filed Civil Money Penalty (CMP) lawsuits against 50 e-cigarette companies, alleging they manufactured unauthorized products, and is coordinating with the Department of Justice to seek injunctions against seven companies manufacturing unauthorized e-cigarette products.

 

The FDA will continue to take regulatory and enforcement actions against companies manufacturing, distributing, importing, or selling unauthorized e-cigarette products, including pursuing CMP lawsuits against retailers engaged in illegal practices.

 

2FIRSTS also contacted the relevant person in charge of IMiracle (Heaven Gifts), the parent company of the ELFBAR brand, in relation to this incident. Their full response is as follows:

 

Since February 2023, IMiracle (Heaven Gifts) has ceased sales of ELFBAR products in the United States. Market feedback indicates that the current ELFBAR products available in the U.S. are not produced by IMiracle (Heaven Gifts), but rather are sourced from VPR or counterfeit workshops in Southeast Asia. We urge consumers to be vigilant and call on U.S. regulatory authorities to crack down on counterfeit goods at the import level. Additionally, we support efforts by U.S. regulatory agencies to strengthen oversight of counterfeit goods in order to effectively protect consumers from the harm of counterfeit products.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
FDA CTP Director Bret Koplow used his FDLI keynote in Washington to outline how the agency is rethinking the PMTA framework. He discussed category-specific review, nicotine pouch and sPMTA pilots, AI-assisted review, a 70% reduction in pending applications, and a major staffing constraint: CTP currently has only nine scientific review teams. He also reaffirmed tobacco harm reduction while stressing youth protection, flavored products, risk communication, and the challenge of unauthorized e-cigarettes.
Regulations
Oct.06
Virginia Tobacco Retail Permit Takes Effect October 1, Covering Vapes as More Than 3,000 Businesses Apply in September
Virginia Tobacco Retail Permit Takes Effect October 1, Covering Vapes as More Than 3,000 Businesses Apply in September
Virginia's new retail tobacco permit system took effect October 1, requiring sellers of vapes, nicotine products and related devices and accessories to obtain a Retail Tobacco Permit for each business location. Virginia ABC said more than 3,000 businesses applied in September alone, creating a processing backlog. Qualifying applicants that filed before October 1 may temporarily operate under a Letter of Authorization. The new store-level permit also sits alongside Virginia's existing vape product directory, where sales of unlisted liquid nicotine or nicotine vapor products can trigger civil penalties starting at $5,000.
Regulations
Oct.03
Ukraine Raises Excise Stamp Fees for Tobacco, Heated Tobacco and Vape Liquids by 30.5% as Parliament Backs E-Excise Delay to 2027
Ukraine Raises Excise Stamp Fees for Tobacco, Heated Tobacco and Vape Liquids by 30.5% as Parliament Backs E-Excise Delay to 2027
Ukraine's Cabinet of Ministers adopted Resolution No. 1259 on October 15, 2026, increasing excise stamp production fees for tobacco products and e-cigarette liquids by approximately 30.5%, from UAH 0.1643 to UAH 0.2144 per stamp. Fees for alcoholic beverages rose by about 30.2%. Separately, Ukraine's parliament passed Bill No. 15532 on October 13, proposing to postpone the full implementation of electronic excise stamps and traceability for alcohol, tobacco and e-cigarette liquids from November 1, 2026, to July 1, 2027. Parliament cited additional testing, configuration and integration requirements. The bill was sent to the president for signature on October 19.
Regulations
Oct.21
EU Tobacco Tax Reform Stalls as Malta Withholds Support Despite Backing From 26 States
EU Tobacco Tax Reform Stalls as Malta Withholds Support Despite Backing From 26 States
EU finance ministers failed to reach agreement on tobacco excise reform at the November 9, 2026 Economic and Financial Affairs Council (ECOFIN) meeting in Brussels. The Irish Council presidency's compromise secured support from 26 of the EU's 27 member states, but Malta withheld consent, preventing the Council from reaching a general approach requiring unanimity. The reform would raise minimum taxes on conventional tobacco and bring e-cigarette liquids, heated tobacco and nicotine pouches into a common EU minimum excise framework. Finland and Estonia accepted further concessions during the meeting, while the presidency proposed separating the inclusion of nicotine pouches in the framework from setting their precise minimum tax rates. Another compromise would allow ten qualifying member states until 2036 to meet certain tobacco excise requirements. Ireland intends to continue negotiations in December.
Regulations
Nov.11
Athletes Back Skoka's $21.5 Million Nicotine Pouch Venture: Can Its Consumer Health Founder Make an FDA-Focused Strategy Pay Off?
Athletes Back Skoka's $21.5 Million Nicotine Pouch Venture: Can Its Consumer Health Founder Make an FDA-Focused Strategy Pay Off?
U.S. nicotine pouch startup Skoka Inc. has raised $21.5 million and committed $15 million to an FDA regulatory and scientific research program. Founder Dan Aziz previously built dietary supplement brand Premama, which was acquired by Dr. Reddy's Laboratories in 2023. Skoka is combining proprietary formulations, ingredient transparency and equity investment from professional athletes. The company submitted a bundled PMTA covering 55 products on October 1, 2026. Aziz said Skoka declined an opportunity to enter retail in 2025, prioritizing product research and regulatory submissions instead. It now targets a U.S. retail launch in 2027, subject to FDA requirements. Its products have not received marketing authorization.
Business
Nov.04
Sweden Finds ZYN Ingredient Labels Noncompliant Over Generic Flavoring Disclosure, Swedish Match Faces SEK 2 Million Monthly Penalty
Sweden Finds ZYN Ingredient Labels Noncompliant Over Generic Flavoring Disclosure, Swedish Match Faces SEK 2 Million Monthly Penalty
Sweden's Public Health Agency has found ingredient labels on ZYN nicotine pouches sold by Philip Morris International subsidiary Swedish Match to be noncompliant, according to Dagens industri. The products' packaging listed 10 to 13 ingredients, compared with 11 to 42 in regulatory submissions, with multiple flavoring ingredients grouped under the generic term "aromer." The agency ordered corrective action, warning of a conditional penalty of SEK 2 million per month for noncompliance. The order applies only to products manufactured after the decision becomes legally effective and does not require recalls. Swedish Match disputes the agency's interpretation and plans to appeal.
PMI
Oct.22